Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia
Background The increasing incidence of life-threatening Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients is a global concern. Yet, no reports have examined the prognostic significance of pre-existing interstitial lung disease (ILD) in non-HIV PCP. Methods We retrospectively reviewe...
Main Authors: | Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-05-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/6/2/00306-2019.full |
Similar Items
-
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
by: Shohei Hamada, et al.
Published: (2019-04-01) -
The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases
by: Shohei Hamada, et al.
Published: (2024-02-01) -
18F‐FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on 18F‐FDG PET/CT: A case report
by: Kimitaka Akaike, et al.
Published: (2024-07-01) -
18F‐FDG uptake in accessory respiratory muscles shows the respiratory effort of patients with pleuroparenchymal fibroelastosis
by: Hiroko Okabayashi, et al.
Published: (2022-02-01) -
Severe pulmonary alveolar proteinosis with respiratory failure treated by intrapulmonary percussive ventilation
by: Takahiro Tashiro, et al.
Published: (2020-12-01)